Published in Clin Ophthalmol on March 04, 2010
Advances in the management of acute retinal necrosis. Int Ophthalmol Clin (2015) 0.84
Cytomegalovirus retinitis treated with valganciclovir in Wegener's granulomatosis. Clin Ophthalmol (2012) 0.79
Cytomegalovirus and eye. Eye (Lond) (2012) 0.75
Long-term results of oral valganciclovir for treatment of anterior segment inflammation secondary to cytomegalovirus infection. Clin Ophthalmol (2012) 0.75
A systematic review of the associations between dose regimens and medication compliance. Clin Ther (2001) 9.23
Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. J Infect Dis (1992) 3.61
Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. N Engl J Med (1999) 3.38
Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir. Antimicrob Agents Chemother (1991) 2.40
Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol (1993) 1.82
Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial. Ann Intern Med (1997) 1.80
Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients. Antimicrob Agents Chemother (2000) 1.50
Single-dose pharmacokinetics of valganciclovir in HIV- and CMV-seropositive subjects. J Clin Pharmacol (1999) 1.46
Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2. Biochem Biophys Res Commun (1998) 1.43
A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis. N Engl J Med (2002) 1.39
Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic. PLoS Med (2007) 1.33
Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study Group. N Engl J Med (1997) 1.27
Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group. Ophthalmology (1994) 1.21
Valganciclovir. Drugs (2001) 1.15
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. Arch Intern Med (1998) 1.09
Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome. Clin Infect Dis (2003) 1.09
Valganciclovir: a review of its use in the management of CMV infection and disease in immunocompromised patients. Drugs (2005) 1.05
Carrier-mediated intestinal absorption of valacyclovir, the L-valyl ester prodrug of acyclovir: 1. Interactions with peptides, organic anions and organic cations in rats. Biopharm Drug Dispos (1998) 1.04
Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteers. Clin Pharmacokinet (1999) 1.01
Pharmacokinetic profile of ganciclovir after its oral administration and from its prodrug, valganciclovir, in solid organ transplant recipients. Clin Pharmacokinet (2005) 0.98
Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir. Transplant Proc (2005) 0.88
Analysis of cytomegalovirus DNA polymerase (UL54) mutations in solid organ transplant patients receiving valganciclovir or ganciclovir prophylaxis. J Med Virol (2005) 0.87
Cytomegalovirus retinitis in the era of highly active antiretroviral therapy (HAART). Am J Med Sci (1999) 0.87
Pharmacokinetics of valganciclovir and ganciclovir in renal impairment. Clin Pharmacol Ther (2002) 0.86
Opportunistic intraocular infections in AIDS. Trans Am Ophthalmol Soc (1992) 0.85
Natural history of untreated cytomegalovirus retinitis. Lancet (1996) 0.85
Intravitreal foscarnet for cytomegalovirus retinitis in patients with AIDS. J Med Assoc Thai (2005) 0.85
Comparative tolerability of therapies for cytomegalovirus retinitis. Drug Saf (1999) 0.80
Valganciclovir: A new oral alternative for cytomegalovirus retinitis in human immunodeficiency virus-seropositive individuals. Pharmacotherapy (2002) 0.80
Central venous catheter infections in AIDS patients receiving treatment for cytomegalovirus disease. J Acquir Immune Defic Syndr (1994) 0.78
Treatment of cytomegalovirus disease with valganciclovir in renal transplant recipients: a single center experience. Transplantation (2004) 0.78
Five-year follow-up of a cohort of profoundly immunosuppressed patients discontinuing therapy for cytomegalovirus retinitis. AIDS (2004) 0.77
Valganciclovir: a new treatment for cytomegalovirus retinitis. BETA (2002) 0.77
When can cytomegalovirus prophylaxis and maintenance therapy be stopped in HIV disease? Curr Opin Infect Dis (2000) 0.77
Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomized, comparative study. Nephrol Dial Transplant (2003) 0.77
Cost of prophylaxis in the management of cytomegalovirus infection in solid organ transplant recipients. Clin Transplant (2007) 0.77
Pharmacokinetics of oral ganciclovir capsules in HIV-infected persons. AIDS (1996) 0.77
Economic evaluation of systemic treatments for cytomegalovirus retinitis in patients with AIDS. Pharmacoeconomics (2001) 0.76
An integrative approach for in silico glioma research. IEEE Trans Biomed Eng (2010) 4.55
Endoscopic ultrasound as a first test for diagnosis and staging of lung cancer: a prospective study. Am J Respir Crit Care Med (2006) 3.35
Integrated morphologic analysis for the identification and characterization of disease subtypes. J Am Med Inform Assoc (2012) 2.68
A data model and database for high-resolution pathology analytical image informatics. J Pathol Inform (2011) 2.54
Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci (2011) 2.53
GridIMAGE: a novel use of grid computing to support interactive human and computer-assisted detection decision support. J Digit Imaging (2007) 2.21
Second-harmonic imaging microscopy of normal human and keratoconus cornea. Invest Ophthalmol Vis Sci (2007) 1.97
Rb is critical in a mammalian tissue stem cell population. Genes Dev (2007) 1.92
Informatics in radiology: GridCAD: grid-based computer-aided detection system. Radiographics (2007) 1.84
Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Arch Ophthalmol (2010) 1.82
Evidence of oxidative stress in human corneal diseases. J Histochem Cytochem (2002) 1.76
Imaging pulsatile retinal blood flow in human eye. J Biomed Opt (2008) 1.73
Cognitive impairment in people diagnosed with end-stage liver disease evaluated for liver transplantation. Psychiatry Clin Neurosci (2006) 1.70
Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome. Am J Ophthalmol (2009) 1.64
Integrative, multimodal analysis of glioblastoma using TCGA molecular data, pathology images, and clinical outcomes. IEEE Trans Biomed Eng (2011) 1.63
Correlation of visual acuity and macular thickness measured by optical coherence tomography in patients with persistent macular edema. Retina (2010) 1.56
Decrease in the oral bioavailability of dabigatran etexilate after co-medication with rifampicin. Br J Clin Pharmacol (2012) 1.53
Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema. Ophthalmology (2013) 1.52
Noninvasive corneal stromal collagen imaging using two-photon-generated second-harmonic signals. J Cataract Refract Surg (2006) 1.48
Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema. Clin Ophthalmol (2011) 1.46
Sutureless 23-gauge versus 20-gauge vitrectomy with silicone oil injection in rhegmatogenous retinal detachment. Retina (2012) 1.46
Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes. Invest Ophthalmol Vis Sci (2011) 1.46
Improving normal tissue complication probability models: the need to adopt a "data-pooling" culture. Int J Radiat Oncol Biol Phys (2010) 1.44
Pseudophakic corneal edema: A review of mechanisms and treatments. Cornea (2006) 1.43
ImageMiner: a software system for comparative analysis of tissue microarrays using content-based image retrieval, high-performance computing, and grid technology. J Am Med Inform Assoc (2011) 1.40
Sharing data and analytical resources securely in a biomedical research Grid environment. J Am Med Inform Assoc (2008) 1.36
Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant. Ophthalmology (2012) 1.32
e-Science, caGrid, and Translational Biomedical Research. Computer (Long Beach Calif) (2008) 1.32
Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary study. Am J Ophthalmol (2007) 1.26
SOD1: a candidate gene for keratoconus. Invest Ophthalmol Vis Sci (2006) 1.26
Mitochondrial DNA haplogroups associated with age-related macular degeneration. Invest Ophthalmol Vis Sci (2009) 1.26
Evaluation of in vitro effects of bevacizumab (Avastin) on retinal pigment epithelial, neurosensory retinal, and microvascular endothelial cells. Retina (2006) 1.25
Compositional differences between infant and adult human corneal basement membranes. Invest Ophthalmol Vis Sci (2007) 1.25
Optimizing diagnosis and management of nocardia keratitis, scleritis, and endophthalmitis: 11-year microbial and clinical overview. Ophthalmology (2011) 1.22
Behavioral manifestations of sturge-weber syndrome: a case report. Prim Care Companion J Clin Psychiatry (2006) 1.22
Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema. Ophthalmology (2005) 1.22
Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications. Invest Ophthalmol Vis Sci (2010) 1.17
Ocular changes after photodynamic therapy. Invest Ophthalmol Vis Sci (2006) 1.17
Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells. Invest Ophthalmol Vis Sci (2006) 1.16
Antibiotic prescribing in outpatients: Hospital and seasonal variations in Ujjain, India. Scand J Infect Dis (2011) 1.14
Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation. Arch Ophthalmol (2009) 1.13
Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression. Ophthalmology (2004) 1.13
Increased stress-induced generation of reactive oxygen species and apoptosis in human keratoconus fibroblasts. Invest Ophthalmol Vis Sci (2006) 1.13
Managing and Querying Image Annotation and Markup in XML. Proc SPIE Int Soc Opt Eng (2010) 1.10
Suppression of signal transducer and activator of transcription 3 activation by butein inhibits growth of human hepatocellular carcinoma in vivo. Clin Cancer Res (2010) 1.09
Psychogenic polydipsia. Indian J Psychiatry (2011) 1.08
Ranibizumab. Nat Rev Drug Discov (2006) 1.08
Trypan blue: effect on retinal pigment epithelial and neurosensory retinal cells. Invest Ophthalmol Vis Sci (2005) 1.07
Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment. Ophthalmology (2004) 1.07
Wet age-related macular degeneration. Adv Drug Deliv Rev (2005) 1.06
Accumulation of mitochondrial DNA damage in keratoconus corneas. Invest Ophthalmol Vis Sci (2005) 1.06
Hypersensitive response to oxidative stress in keratoconus corneal fibroblasts. Invest Ophthalmol Vis Sci (2008) 1.06
Protocol modifications for CT perfusion (CTp) examinations of abdomen-pelvic tumors: impact on radiation dose and data processing time. Eur Radiol (2011) 1.05
Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice. J Mol Med (Berl) (2011) 1.05
Uncertain compassion in using a drug before the risks and benefits are known. Arch Ophthalmol (2006) 1.05
Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000). Am J Ophthalmol (2008) 1.02
Evaluation of techniques using amplified nucleic acid probes for gene expression profiling. Biomol Eng (2003) 1.01
A roadmap for caGrid, an enterprise Grid architecture for biomedical research. Stud Health Technol Inform (2008) 1.01
Surveillance of antibiotic consumption using the "focus of infection" approach in 2 hospitals in Ujjain, India. PLoS One (2012) 1.00
Effects of tenascin-C on normal and diabetic retinal endothelial cells in culture. Invest Ophthalmol Vis Sci (2002) 1.00
Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C. J Hepatol (2002) 0.99
Effects of angiogenic growth factor combinations on retinal endothelial cells. Exp Eye Res (2002) 0.98
Acute pancreatitis after EUS-guided FNA of solid pancreatic masses: a pooled analysis from EUS centers in the United States. Gastrointest Endosc (2004) 0.98
Enhancement of Cellulase Activity from a New Strain of Bacillus subtilis by Medium Optimization and Analysis with Various Cellulosic Substrates. Enzyme Res (2011) 0.97
HPC AND GRID COMPUTING FOR INTEGRATIVE BIOMEDICAL RESEARCH. Int J High Perform Comput Appl (2009) 0.97
Assessment of the differences in pharmacokinetics and pharmacodynamics between four distinct formulations of triamcinolone acetonide. Retina (2013) 0.97
Mitochondrial DNA variants mediate energy production and expression levels for CFH, C3 and EFEMP1 genes: implications for age-related macular degeneration. PLoS One (2013) 0.96
Inflammasome-mediated IL-1β production in humans with cystic fibrosis. PLoS One (2012) 0.95
Intravitreous dexamethasone effects on different patterns of diabetic macular edema. Arch Ophthalmol (2010) 0.95
Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells. Br J Pharmacol (2011) 0.95
Safety profile of ocriplasmin for the pharmacologic treatment of symptomatic vitreomacular adhesion/traction. Retina (2015) 0.95
Alu DNA polymorphism in ACE gene is protective for age-related macular degeneration. Biochem Biophys Res Commun (2002) 0.94
Oxysterol-induced toxicity in R28 and ARPE-19 cells. Neurochem Res (2003) 0.93
Intestinal expression of genes involved in iron absorption in humans. Am J Physiol Gastrointest Liver Physiol (2002) 0.93
Elements of the nitric oxide pathway can degrade TIMP-1 and increase gelatinase activity. Mol Vis (2004) 0.92
Efficacy of anti-vascular endothelial growth factor therapy in subretinal neovascularization secondary to macular telangiectasia type 2. Retina (2012) 0.92
Genotypic analysis of cytomegalovirus retinitis poorly responsive to intravenous ganciclovir but responsive to the ganciclovir implant. Am J Ophthalmol (2003) 0.92
Estimation of salivary and tongue coating pH on chewing household herbal leaves: A randomized controlled trial. Anc Sci Life (2012) 0.91
Enhanced fibrinolysis protects against lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg (2009) 0.91
Mitochondrial DNA damage induced by 7-ketocholesterol in human retinal pigment epithelial cells in vitro. Invest Ophthalmol Vis Sci (2009) 0.90
Dual epidermal growth factor receptor (EGFR)/insulin-like growth factor-1 receptor (IGF-1R) inhibitor: a novel approach for overcoming resistance in anticancer treatment. Eur J Pharmacol (2011) 0.90
Intraocular sustained-release delivery systems for triamcinolone acetonide. Pharm Res (2009) 0.90
Percutaneous transcatheter arterial embolization of inferior pancreatico-duodenal artery aneurysms associated with celiac artery stenosis or occlusion. Catheter Cardiovasc Interv (2010) 0.89
Levetiracetam-induced acute psychotic episode. Innov Clin Neurosci (2012) 0.89
Challenges in containing the burden of hepatitis B infection in dialysis and transplant patients in India. Nephrology (Carlton) (2011) 0.89
Caspase-8, -12, and -3 activation by 7-ketocholesterol in retinal neurosensory cells. Invest Ophthalmol Vis Sci (2007) 0.89
Effects of Benzo(e)Pyrene, a toxic component of cigarette smoke, on human retinal pigment epithelial cells in vitro. Invest Ophthalmol Vis Sci (2008) 0.89
Biochemical properties, pharmacokinetics and pharmacological response of tiotropium in chronic obstructive pulmonary disease patients. Expert Opin Drug Metab Toxicol (2009) 0.88
Optical coherence tomography in progressive outer retinal necrosis. Ophthalmic Surg Lasers Imaging (2006) 0.86
Effects of a superoxide dismutase mimetic on biomarkers of lung angiogenesis and alveolarization during hyperoxia with intermittent hypoxia. Am J Transl Res (2013) 0.86
Extracellular matrix and matrix metalloproteinase changes in human corneas after complicated laser-assisted in situ keratomileusis (LASIK). Cornea (2002) 0.86
An acetazolamide based multimodal analgesic approach versus conventional pain management in patients undergoing laparoscopic living donor nephrectomy. Indian J Anaesth (2009) 0.85
Outcomes associated with ganciclovir implants in patients with AIDS-related cytomegalovirus retinitis. Ophthalmology (2006) 0.85